FDA - Food and Drug Administration

Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds

GentaGel’s biodegradable treatment releases antibiotics directly at infection sites for up to 60 days; the company is pursuing further trials and an FDA regulatory pathway.

Dr. Ariel Orbach (L), Co-Founder and CEO of GentaGel, Prof. Avi Domb (M), Inventor of GentaGel-LR Technology, and Eli Lerner (R), Co-founder and COO of GentaGel.
Menta "Steve" Wallace shows a bottle of daraxonrasib, Revolution Medicine?s pancreatic cancer drug, at his home in The Woodlands, Texas, U.S., May 29, 2026.

Revolution Medicines gets FDA approval for targeted pancreatic cancer drug

A close-up view of a large pile of green jalapeño peppers

What do we know about the multistate salmonella outbreak in the US? - explainer

The logo of US supplier Taylor Farms at the company's installations following the temporary closure announced by Taylor Farms, in Doctor Mora, Guanajuato state, Mexico, July 24, 2026.

Taylor Farms recalls salsa, guacamole over salmonella risk, weeks after cyclosporiasis concerns


'Miracle cure': 2-year-old steals show at White House announcement of hearing loss therapy approval

Most patients began to hear within weeks, with 80% achieving at least significant hearing restoration and 42% reaching normal hearing, including the ability to hear whispers.

A person cups their hand to their ear in an act of listening (illustrative)

Trump signs order to accelerate Ibogaine research for veterans with PTSD 

The order focuses on advancing studies of ibogaine, a Schedule I psychedelic drug, for use in treating PTSD, traumatic brain injury, depression, anxiety, suicidal ideatiation, and opiod addiction.

 U.S. President Donald Trump signs an executive order encouraging more research into ibogaine, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Joe Rogan, and Americans for Ibogaine CEO W. Bryan Hubbard, in the Oval Office of the White House in Washington, D.C., April 18

Israeli pride: Phytolon receives FDA approval – sparks significant interest in the U.S.

Millennium FoodTech R&D Partnership: Portfolio company Phytollon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S.

Portfolio company Phytoon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S

FDA clears AI model to triage urgent CT findings, Israeli firm says

Aidoc won FDA clearance for a 'foundation model' clinical AI that triages 14 abdomen-CT indications in one workflow, aiming to surface urgent findings faster amid ED crowding and imaging backlogs.

(Illustrative) A doctor uses AI for a medical screening.

FDA clears first US trial of Israel’s EndoArt synthetic corneal implant

EyeYon Medical says FDA granted IDE for a multicenter study led by Scripps Clinic’s Prof. Francis Mah, with enrollment targeted to begin in March 2026.

ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.

Arizona couple admits in court to faking cancer-curing 'smart chip' device

At clinics in Arizona and several other states, Mary Blakley and her husband told patients that, for just $300, they could provide a full-body scan to detect a variety of potential illnesses.

 Dividing cancer cell

Forget the injections: The FDA has approved a daily weight-loss pill for the first time

A daily pill version of the weight-loss drug Wegovy shows significant weight reduction, greater convenience, and hope for making treatment accessible to millions of patients.

Wegovy pills

Weight-loss pill approval set to accelerate food industry product overhauls

As GLP-1 pills become widely available, food companies and restaurants are adjusting to rising demand for high-protein, smaller portions to meet weight-loss trends.

Semaglutide pills; illustrative.

Kennedy seeks to cut US children's access to gender-affirming care

Kennedy proposed rules barring hospitals that provide such care from participating in Medicare and Medicaid programs and prohibiting Medicaid from paying for it.

US Secretary of Health and Human Services Robert F. Kennedy Jr. speaks with US Vice President JD Vance (not pictured) during the inaugural Make America Healthy Again (MAHA) summit in Washington, DC, US, November 12, 2025.

Israeli firm receives FDA approval to begin clinical trial of chronic corneal edema treatment

The company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.

ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.